Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors
NCT06556108Phase 2Completed
- Sponsor
- Xinqiao Hospital
- Start
- Jan 2018
- Primary completion
- Jan 2025
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ALPP CAR-T cells in solid tumor (advanced stage), sponsored by Xinqiao Hospital. Started Jan 2018; status: completed.
02
Drugs
ALPP CAR-T cells
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06556108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06556108.